WNT/β-catenin increases the production of incretins by entero-endocrine cells

Diabetologia

Volumn 52, Issue 9, 2009, Pages 1913-1924

  Garcia Martinez J M ^a   Chocarro Calvo, A ^a   Moya, C M ^b   Garcia Jimenez C ^a  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

^b CSIC   (Spain)

Author keywords

Catenin; Chromatin; Diabetes; Glucose dependent insulinotropic peptide; Incretin; Lithium; Obesity; WNT

Indexed keywords

BETA CATENIN; GASTRIC INHIBITORY POLYPEPTIDE; HISTONE DEACETYLASE 1; INCRETIN; LITHIUM; T CELL FACTOR 4; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL CELL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DELETION MUTANT; DIABETES MELLITUS; ENTEROENDOCRINE CELL; GEL MOBILITY SHIFT ASSAY; GENE; GENE EXPRESSION; GENE INDUCTION; GIP GENE; HUMAN; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; BETA CATENIN; CELL LINE, TUMOR; CHROMATIN; DNA, NEOPLASM; GASTRIC INHIBITORY POLYPEPTIDE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; INCRETINS; INTESTINAL NEOPLASMS; LITHIUM; LUCIFERASES; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SIGNAL TRANSDUCTION; TRANSFECTION; WNT PROTEINS;

EID: 68449097985     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-009-1429-1     Document Type: Article

References (50)

1. VA Gault N Irwin P Harriott PR Flatt FP O'Harte 2003 DPP IV resistance and insulin releasing activity of a novel di-substituted analogue of glucose-dependent insulinotropic polypeptide, (Ser2-Asp13)GIP Cell Biol Int 27 41 46
2. CC Tseng MO Boylan LA Jarboe TB Usdin MM Wolfe 1996 Chronic desensitization of the glucose-dependent insulinotropic polypeptide receptor in diabetic rats Am J Physiol 270 E661 E666
3. B Beck 1989 Gastric inhibitory polypeptide: a gut hormone with anabolic functions J Mol Endocrinol 2 169 174
4. Y Yamada Y Seino 2004 Physiology of GIP-a lesson from GIP receptor knockout mice Horm Metab Res 36 771 774
5. T Hansotia LL Baggio D Delmeire 2004 Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors Diabetes 53 1326 1335
6. MC Althage EL Ford S Wang P Tso KS Polonsky BM Wice 2008 Targeted ablation of glucose-dependent insulinotropic polypeptide-producing cells in transgenic mice reduces obesity and insulin resistance induced by a high fat diet J Biol Chem 283 18365 18376
7. PL McClean N Irwin RS Cassidy JJ Holst VA Gault PR Flatt 2007 GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet Am J Physiol Endocrinol Metab 293 E1746 E1755
8. K Miyawaki Y Yamada H Yano 1999 Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice Proc Natl Acad Sci U S A 96 14843 14847
9. C Yamada Y Yamada K Tsukiyama 2007 Genetic inactivation of GIP signaling reverses aging-associated insulin resistance through body composition changes Biochem Biophys Res Commun 364 175 180
10. T Hansotia A Maida G Flock 2007 Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure J Clin Invest 117 143 152
11. JJ Meier MA Nauck WE Schmidt B Gallwitz 2002 Gastric inhibitory polypeptide: the neglected incretin revisited Regul Pept 107 1 13
12. HJ Welters RN Kulkarni 2008 Wnt signaling: relevance to beta-cell biology and diabetes Trends Endocrinol Metab 19 349 355
13. H Clevers 2006 Wnt/beta-catenin signaling in development and disease Cell 127 469 480
14. J Roose H Clevers 1999 TCF transcription factors: molecular switches in carcinogenesis Biochim Biophys Acta 1424 M23 M37
15. PS Klein DA Melton 1996 A molecular mechanism for the effect of lithium on development Proc Natl Acad Sci U S A 93 8455 8459
16. CM Hedgepeth LJ Conrad J Zhang HC Huang VM Lee PS Klein 1997 Activation of the Wnt signaling pathway: a molecular mechanism for lithium action Dev Biol 185 82 91
17. Z Ni Y Anini X Fang G Mills PL Brubaker T Jin 2003 Transcriptional activation of the proglucagon gene by lithium and beta-catenin in intestinal endocrine L cells J Biol Chem 278 1380 1387
18. F Yi PL Brubaker T Jin 2005 TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta J Biol Chem 280 1457 1464
19. B Gustafson U Smith 2008 WNT signalling is both an inducer and effector of glucagon-like peptide-1 Diabetologia 51 1768 1770
20. MO Boylan LI Jepeal LA Jarboe MM Wolfe 1997 Cell-specific expression of the glucose-dependent insulinotropic polypeptide gene in a mouse neuroendocrine tumor cell line J Biol Chem 272 17438 17443
21. LI Jepeal Y Fujitani MO Boylan CN Wilson CV Wright MM Wolfe 2005 Cell-specific expression of glucose-dependent-insulinotropic polypeptide is regulated by the transcription factor PDX-1 Endocrinology 146 383 391
22. LI Jepeal MO Boylan M Michael Wolfe 2008 GATA-4 upregulates glucose-dependent insulinotropic polypeptide expression in cells of pancreatic and intestinal lineage Mol Cell Endocrinol 287 20 29
23. Y Fujita JW Chui DS King 2008 Pax6 and Pdx1 are required for production of glucose-dependent insulinotropic polypeptide in proglucagon-expressing L cells Am J Physiol Endocrinol Metab 295 E648 E657
24. D Pinto A Gregorieff H Begthel H Clevers 2003 Canonical Wnt signals are essential for homeostasis of the intestinal epithelium Genes Dev 17 1709 1713
25. Y Wang M Giel-Moloney G Rindi AB Leiter 2007 Enteroendocrine precursors differentiate independently of Wnt and form serotonin expressing adenomas in response to active beta-catenin Proc Natl Acad Sci U S A 104 11328 11333
26. G Rindi SG Grant Y Yiangou 1990 Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice. Heterogeneity of hormone expression Am J Pathol 136 1349 1363
27. Schug J (2008) Using TESS to predict transcription factor binding sites in DNA sequence. Curr Protoc Bioinformatics Chapter 2: Unit 2.6
28. JR Munoz-Montano F Lim FJ Moreno J Avila J Diaz-Nido 1999 Glycogen synthase kinase-3 modulates neurite outgrowth in cultured neurons: possible implications for neurite pathology in Alzheimer's disease J Alzheimers Dis 1 361 378
29. NC Andrews DV Faller 1991 A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells Nucleic Acids Res 19 2499
30. J Goodall S Martinozzi TJ Dexter 2004 Brn-2 expression controls melanoma proliferation and is directly regulated by beta-catenin Mol Cell Biol 24 2915 2922
31. KJ Livak TD Schmittgen 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 402 408
32. RS Jope 2003 Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes Trends Pharmacol Sci 24 441 443
33. WJ Ryves AJ Harwood 2001 Lithium inhibits glycogen synthase kinase-3 by competition for magnesium Biochem Biophys Res Commun 280 720 725
34. A Wada H Yokoo T Yanagita H Kobayashi 2005 Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseases J Pharmacol Sci 99 307 321
35. T Yanagita T Maruta Y Uezono 2007 Lithium inhibits function of voltage-dependent sodium channels and catecholamine secretion independent of glycogen synthase kinase-3 in adrenal chromaffin cells Neuropharmacology 53 881 889
36. MH Liang JR Wendland DM Chuang 2008 Lithium inhibits Smad3/4 transactivation via increased CREB activity induced by enhanced PKA and AKT signaling Mol Cell Neurosci 37 440 453
37. V Korinek N Barker PJ Morin 1997 Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma Science 275 1784 1787
38. MT Veeman DC Slusarski A Kaykas SH Louie RT Moon 2003 Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements Curr Biol 13 680 685
39. M Asally Y Yoneda 2005 Beta-catenin can act as a nuclear import receptor for its partner transcription factor, lymphocyte enhancer factor-1 (lef-1) Exp Cell Res 308 357 363
40. V Lyssenko R Lupi P Marchetti 2007 Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes J Clin Invest 117 2155 2163
41. JC Florez KA Jablonski N Bayley 2006 TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program N Engl J Med 355 241 250
42. K Miyawaki Y Yamada N Ban 2002 Inhibition of gastric inhibitory polypeptide signaling prevents obesity Nat Med 8 738 742
43. CB Chan RA Pederson AM Buchan KB Tubesing JC Brown 1984 Gastric inhibitory polypeptide (GIP) and insulin release in the obese Zucker rat Diabetes 33 536 542
44. RA Pederson RV Campos AM Buchan CB Chisholm JC Russell JC Brown 1991 Comparison of the enteroinsular axis in two strains of obese rat, the fatty Zucker and the JCR:LA-corpulent Int J Obes 15 461 470
45. JC Brown S Otte 1979 Clinical studies with gastric inhibitory polypeptide World J Surg 3 553 558
46. IR Jones DR Owens S Luzio TM Hayes 1989 Glucose dependent insulinotropic polypeptide (GIP) infused intravenously is insulinotropic in the fasting state in type 2 (non-insulin dependent) diabetes mellitus Horm Metab Res 21 23 26 (Pubitemid 19060064)
47. IR Jones DR Owens S Luzio S Williams TM Hayes 1989 The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with type 2 (non-insulin-dependent) diabetes mellitus Diabetologia 32 668 677
48. FK Knop T Vilsboll PV Hojberg 2007 The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance Regul Pept 144 123 130
49. JJ Meier K Hucking JJ Holst CF Deacon WH Schmiegel MA Nauck 2001 Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes Diabetes 50 2497 2504 (Pubitemid 33642767)
50. B Kim SJ Kim JI Son YH Joo 2008 Weight change in the acute treatment of bipolar I disorder: a naturalistic observational study of psychiatric inpatients J Affect Disord 105 45 52